Recent News

• 02.12.2026 - BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
• 01.20.2026 - Advancing Cell and Gene Therapy Manufacturing Through Collaboration: BioLife Partners with ScaleReady and the Emily Whitehead Foundation
• 01.12.2026 - BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations

Recent Filings

• 01.12.2026 - 8-K Current report
• 01.12.2026 - EX-99.1 EX-99.1
• 01.09.2026 - 8-K Current report
• 01.08.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.17.2025 - 4 Statement of changes in beneficial ownership of securities